Citadel Advisors
RCEL icon

Citadel Advisors’s Avita Medical RCEL Stock Holding History

Citadel Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,700
Closed -$127K – 14007
2025
Q4 		$127K Buy
36,700
+3,100
+9% +$12.4K ﹤0.01% 11454
2025
Q3 		$172K Sell
33,600
-1,100
-3% -$5.74K ﹤0.01% 11417
2025
Q2 		$184K Sell
34,700
-1,700
-5% -$12.4K ﹤0.01% 10756
2025
Q1 		$296K Buy
36,400
+7,600
+26% +$71K ﹤0.01% 9633
2024
Q4 		$369K Buy
28,800
+7,900
+38% +$93.2K ﹤0.01% 9241
2024
Q3 		$224K Buy
20,900
+9,300
+80% +$87.4K ﹤0.01% 9917
2024
Q2 		$91.9K Sell
11,600
-8,200
-41% -$78K ﹤0.01% 11038
2024
Q1 		$317K Buy
19,800
+500
+3% +$8.09K ﹤0.01% 9335
2023
Q4 		$265K Sell
19,300
-6,700
-26% -$76.8K ﹤0.01% 9401
2023
Q3 		$380K Sell
26,000
-20,200
-44% -$342K ﹤0.01% 8667
2023
Q2 		$786K Buy
46,200
+32,700
+242% +$480K ﹤0.01% 6965
2023
Q1 		$189K Sell
13,500
-38,800
-74% -$413K ﹤0.01% 10282
2022
Q4 		$345K Sell
52,300
-35,300
-40% -$212K ﹤0.01% 9009
2022
Q3 		$462K Buy
87,600
+59,200
+208% +$366K ﹤0.01% 8642
2022
Q2 		$135K Buy
28,400
+1,500
+6% +$9.27K ﹤0.01% 11091
2022
Q1 		$228K Sell
26,900
-3,500
-12% -$32.3K ﹤0.01% 11213
2021
Q4 		$364K Buy
30,400
+17,900
+143% +$273K ﹤0.01% 10480
2021
Q3 		$222K Buy
+12,500
New +$236K ﹤0.01% 11765
2021
Q1 		– Sell
-11,740
Closed -$218K – 13623
2020
Q4 		$218K Buy
11,740
+3,640
+45% +$79.8K ﹤0.01% 9611
2020
Q3 		$204K Buy
+8,100
New +$202K ﹤0.01% 8766

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors's RCEL Position: Q2 2026 in Review

Citadel Advisors reduced its Avita Medical (RCEL) stake by 17% in Q2 2026, selling an estimated $18.9K and leaving 21,246 shares worth $87.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12782.

Citadel Advisors first reported a position in RCEL in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.52M in Q1 2023. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Citadel Advisors held 21,246 shares of Avita Medical worth $87.7K as of Q2 2026.
  • Citadel Advisors sold 4,378 Avita Medical shares in Q2 2026, an estimated $18.9K.
  • Avita Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12782 holding.
  • Citadel Advisors first reported a position in Avita Medical in Q4 2019 and has held it in 20 quarters since.
  • Citadel Advisors's Avita Medical position peaked at $1.52M in Q1 2023.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.